Journal of Virology · 1999 · 156 citations · 35 references
Life SciencesImmunologyInfectious DiseasesImmunology Of Infectious DiseasesInnate ImmunityVaccinologyCellular Immunity In InfectionDna VaccinesInactivated VaccinesNatural Killer Cell BiologyVaccinationViral VaccinesInterferon Gamma ProductionLung Immune ResponsePulmonary Immune ResponsePulmonary ImmunopathologyRespiratory Syncytial Virus VaccinesRespiratory Viral PathogenesisRespiratory Viral PathologyTh2 Immune Response
BALB/c mice sensitized to vaccinia virus expressed G protein of respiratory syncytial virus (RSV) develop a Th2-type cytokine response and pulmonary eosinophilia when challenged with live RSV. In this study, BALB/c mice were immunized or challenged with an RSV mutant lacking the G and SH proteins or with DNA vaccines coding for RSV G or F protein. F or G protein DNA vaccines were capable of sensitizing for pulmonary eosinophilia. The absence of the G and/or SH protein in the infecting virus resulted in a consistent increase both in pulmonary natural killer cells and in gamma interferon and tumor necrosis factor expression, as well as, with primary infection, a variable increase in neutrophils and CD11b(+) cells. The development of pulmonary eosinophilia in formalin-inactivated RSV-vaccinated mice required the presence of the G and/or SH protein in the challenge virus. These data show that G and/or SH protein has a marked impact on the inflammatory and innate immune response to RSV infection.
35
Ruth A. Karron, Deborah A. Buonagurio, Alice Georgiu et al. · Proceedings of the National Academy of Sciences · 1997 · 416 citations · Full text
Mark Connors, Nathalia A. Giese, Arun B. Kulkarni et al. · Journal of Virology · 1994 · 349 citations · Full text
Life Sciences, Immunology, Pathology +17